project id: TCGA-GBM; case submitter id: TCGA-06-A6S1; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 8.8; age at index: 53; days to birth: -19443; days to death: 78; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1959; year of death: 2012; age at diagnosis: 19443; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: No; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 282; initial weight: 300.0; oct embedded: false; preservation method: Unknown; sample id: dae09357-454a-4a7a-a2bf-27e0f5bbc1b5; sample submitter id: TCGA-06-A6S1-01A; portion id: b33a12db-80fb-4503-8d9e-15e8675ddb54; portion submitter id: TCGA-06-A6S1-01A-11; slide id: 94347760-76fa-44e3-b5f8-8fd09771b2ef; slide submitter id: TCGA-06-A6S1-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 40.0; percent tumor cells: 40.0; percent tumor nuclei: 80.0; section location: TOP;